These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21279152)

  • 1. Hepatitis A, B and nAnB: The Viruses and their Prevention.
    Minuk GY
    Can Fam Physician; 1985 Jan; 31():120-3. PubMed ID: 21279152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-A, non-B hepatitis: evolving epidemiologic and clinical perspective.
    Dienstag JL; Alter HJ
    Semin Liver Dis; 1986 Feb; 6(1):67-81. PubMed ID: 3012784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sterilisation of hepatitis and HTLV-III viruses by exposure to tri(n-butyl)phosphate and sodium cholate.
    Prince AM; Horowitz B; Brotman B
    Lancet; 1986 Mar; 1(8483):706-10. PubMed ID: 2870224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Living related liver transplantation for hepatitis B-related liver disease without hepatitis B immune globulin prophylaxis.
    Wadhawan M; Gupta S; Goyal N; Taneja S; Kumar A
    Liver Transpl; 2013 Sep; 19(9):1030-5. PubMed ID: 23788470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy.
    Han SH; Ofman J; Holt C; King K; Kunder G; Chen P; Dawson S; Goldstein L; Yersiz H; Farmer DG; Ghobrial RM; Busuttil RW; Martin P
    Liver Transpl; 2000 Nov; 6(6):741-8. PubMed ID: 11084061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fulminant hepatitis in patients undergoing liver transplantation: evidence for a non-A, non-B, non-C, non-D, and non-E syndrome.
    Ferraz ML; Silva AE; Macdonald GA; Tsarev SA; Di Biscelgie AM; Lucey MR
    Liver Transpl Surg; 1996 Jan; 2(1):60-6. PubMed ID: 9346629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of lamivudine and adefovir without hepatitis B immune globulin is safe and effective prophylaxis against hepatitis B virus recurrence in hepatitis B surface antigen-positive liver transplant candidates.
    Gane EJ; Patterson S; Strasser SI; McCaughan GW; Angus PW
    Liver Transpl; 2013 Mar; 19(3):268-74. PubMed ID: 23447403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of hepatitis B recurrence after liver transplantation using lamivudine and hepatitis B immune globulin.
    Ołdakowska-Jedynak U; Paczek L; Foroncewicz B; Mucha K; Nyckowski P; Zieniewicz K; Ziarkiewicz-Wróblewska B; Ziółkowski J; Pilecki T; Patkowski W; Górnicka B; Paczkowska A; Krawczyk M
    Ann Transplant; 2007; 12(3):28-32. PubMed ID: 18290567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence-free long-term survival after liver transplantation for hepatitis B using interferon-alpha pretransplant and hepatitis B immune globulin posttransplant.
    Tchervenkov JI; Tector AJ; Barkun JS; Sherker A; Forbes CD; Elias N; Cantarovich M; Cleland P; Metrakos P; Meakins JL
    Ann Surg; 1997 Sep; 226(3):356-65; discussion 365-8. PubMed ID: 9339942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and effectiveness of anti-HBV therapy with early withdrawal of HBIG prophylaxis to prevent HBV recurrence following liver transplantation.
    Ku W; Wang U; Nguyen MH
    Expert Opin Biol Ther; 2015 May; 15(5):665-77. PubMed ID: 25865452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral hepatitis and the anaesthetist.
    Browne RA; Chernesky MA
    Can Anaesth Soc J; 1984 May; 31(3 Pt 1):279-86. PubMed ID: 6426756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved clinical outcomes with liver transplantation for hepatitis B-induced chronic liver failure using passive immunization.
    Sawyer RG; McGory RW; Gaffey MJ; McCullough CC; Shephard BL; Houlgrave CW; Ryan TS; Kuhns M; McNamara A; Caldwell SH; Abdulkareem A; Pruett TL
    Ann Surg; 1998 Jun; 227(6):841-50. PubMed ID: 9637547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation.
    Protzer-Knolle U; Naumann U; Bartenschlager R; Berg T; Hopf U; Meyer zum Büschenfelde KH; Neuhaus P; Gerken G
    Hepatology; 1998 Jan; 27(1):254-63. PubMed ID: 9425945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HBIg discontinuation with maintenance oral anti-viral therapy and HBV vaccination in liver transplant recipients.
    Weber NK; Forman LM; Trotter JF
    Dig Dis Sci; 2010 Feb; 55(2):505-9. PubMed ID: 19802696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of hepatitis B immune globulin to protect against exp infection in chimpanzees.
    Wahl M; Iwarson S; Snoy P; Gerety RJ
    J Hepatol; 1989 Sep; 9(2):198-203. PubMed ID: 2809160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete hepatitis B virus prophylaxis withdrawal in hepatitis B surface antigen-positive liver transplant recipients after longterm minimal immunosuppression.
    Lenci I; Baiocchi L; Tariciotti L; Di Paolo D; Milana M; Santopaolo F; Manzia TM; Toti L; Svicher V; Tisone G; Perno CF; Angelico M
    Liver Transpl; 2016 Sep; 22(9):1205-13. PubMed ID: 27272189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Passive immunization against exposure to hepatitis B virus in the military: potential and possibilities.
    Irwin GR
    Yale J Biol Med; 1976 Jul; 49(3):251-7. PubMed ID: 60830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to an experimental HBV vaccine permits withdrawal of HBIg prophylaxis in fulminant and selected chronic HBV-infected liver graft recipients.
    Stärkel P; Stoffel M; Lerut J; Horsmans Y
    Liver Transpl; 2005 Oct; 11(10):1228-34. PubMed ID: 16184571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute viral hepatitis in Lebanon: evidence for a HAV-like non-A non-B hepatitis.
    Shamma'a MH
    Liver; 1984 Feb; 4(1):39-44. PubMed ID: 6422181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unrelatedness of factor VIII-derived non-A/non-B hepatitis and hepatitis B virus.
    Fields HA; Berninger M; Nath N; Davis CL; Hammer M; Margolis HS; McCaustland KA; Wheeler CM; Maynard JE; Bradley DW
    J Med Virol; 1983; 11(1):59-65. PubMed ID: 6403666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.